Royalty Pharma plc (FRA:RPD)
Germany
· Delayed Price · Currency is EUR 29.65
+0.23 (0.78%)
Last updated: May 13, 2025
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of €12.64 billion as of May 13, 2025. Its market cap has increased by 6.79% in one year.
Market Cap
12.64B
Enterprise Value
21.29B
Revenue
2.09B
Ranking
n/a
PE Ratio
12.50
Stock Price
€29.65
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has decreased from 14.00B to 12.64B, a decrease of -9.73%. That is a compound annual growth rate of -2.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 12.64B | 15.44% |
| Dec 31, 2024 | 10.95B | -3.17% |
| Dec 29, 2023 | 11.31B | -30.69% |
| Dec 30, 2022 | 16.31B | 8.38% |
| Dec 31, 2021 | 15.05B | -5.23% |
| Dec 31, 2020 | 15.88B | 13.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 305.24B |
| Siemens Aktiengesellschaft | 167.30B |
| Deutsche Telekom AG | 157.96B |
| Allianz SE | 139.42B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 77.76B |
| Rheinmetall AG | 77.10B |
| Siemens Energy AG | 59.07B |
| Merck KGaA | 53.63B |